Sbi Securities Co., Ltd. Xeris Biopharma Holdings, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,907 shares of XERS stock, worth $17,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,907
Previous 1,907
-0.0%
Holding current value
$17,620
Previous $10.5 Million
14.93%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
208Shares Held
89.9MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$95.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$90.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$35.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$33.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.26B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...